Rein Therapeutics, Inc. Fair Value Disclosure
4. Fair Value of Financial Assets
The following tables present information about the Company’s assets that are measured at fair value on a recurring basis and indicate the level of the fair value hierarchy utilized to determine such fair values:
|
|
December 31, 2024 |
|
|||||||||||||
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total |
|
||||
Cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Money market funds |
|
$ |
2,539 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
2,539 |
|
Treasury bills |
|
|
8,341 |
|
|
|
— |
|
|
|
— |
|
|
|
8,341 |
|
|
|
$ |
10,880 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
10,880 |
|
|
|
December 31, 2023 |
|
|||||||||||||
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total |
|
||||
Cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Money market funds |
|
$ |
10,322 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
10,322 |
|
|
|
$ |
10,322 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
10,322 |
|
During the years ended December 31, 2024 and 2023, there were no transfers between levels.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2024 | Apr 7, 2025 | Showing above |
| 2023 | Apr 15, 2024 | |
| 2022 | Mar 20, 2023 | |
| 2019 | Mar 30, 2020 | |
About Fair Value Disclosures
Fair value disclosures classify all assets and liabilities measured at fair value into a three-level hierarchy: Level 1 (quoted market prices), Level 2 (observable inputs like yield curves), and Level 3 (unobservable inputs requiring management estimates). The proportion of Level 3 assets directly reflects how much of the balance sheet depends on internal models rather than market evidence.
Key signals: a growing Level 3 balance relative to total fair-value assets increases valuation uncertainty and earnings volatility risk. Watch for transfers between levels — assets moving from Level 2 to Level 3 often signal deteriorating market liquidity. Unrealized gains and losses on Level 3 positions flow through earnings or other comprehensive income, so large swings deserve scrutiny. For financial institutions, examine the sensitivity disclosures that show how Level 3 valuations change under alternative assumptions. Compare the fair value of debt against its carrying amount to gauge hidden leverage.